204 related articles for article (PubMed ID: 33744871)
1. Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model.
Cheimonidi C; Grivas IN; Sesti F; Kavrochorianou N; Gianniou DD; Taoufik E; Badounas F; Papassideri I; Rizzi F; Tsitsilonis OE; Haralambous S; Trougakos IP
Aging (Albany NY); 2021 Mar; 13(5):6485-6505. PubMed ID: 33744871
[TBL] [Abstract][Full Text] [Related]
2. The molecular chaperone apolipoprotein J/clusterin as a sensor of oxidative stress: implications in therapeutic approaches - a mini-review.
Trougakos IP
Gerontology; 2013; 59(6):514-23. PubMed ID: 23689375
[TBL] [Abstract][Full Text] [Related]
3. Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro.
Shannan B; Seifert M; Leskov K; Boothman D; Pföhler C; Tilgen W; Reichrath J
Anticancer Res; 2006; 26(4A):2707-16. PubMed ID: 16886681
[TBL] [Abstract][Full Text] [Related]
4. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
Bertacchini J; Mediani L; Beretti F; Guida M; Ghalali A; Brugnoli F; Bertagnolo V; Petricoin E; Poti F; Arioli J; Anselmi L; Bari A; McCubrey J; Martelli AM; Cocco L; Capitani S; Marmiroli S
J Cell Physiol; 2019 Jul; 234(7):11188-11199. PubMed ID: 30565691
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of clusterin/apolipoprotein J on cellular growth and survival.
Trougakos IP; Lourda M; Agiostratidou G; Kletsas D; Gonos ES
Free Radic Biol Med; 2005 Feb; 38(4):436-49. PubMed ID: 15649646
[TBL] [Abstract][Full Text] [Related]
6. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.
Caporali A; Davalli P; Astancolle S; D'Arca D; Brausi M; Bettuzzi S; Corti A
Carcinogenesis; 2004 Nov; 25(11):2217-24. PubMed ID: 15358631
[TBL] [Abstract][Full Text] [Related]
7. Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases.
Trougakos IP; Gonos ES
Free Radic Res; 2006 Dec; 40(12):1324-34. PubMed ID: 17090421
[TBL] [Abstract][Full Text] [Related]
8. Nuclear clusterin accumulation during heat shock response: implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells.
Caccamo AE; Desenzani S; Belloni L; Borghetti AF; Bettuzzi S
J Cell Physiol; 2006 Apr; 207(1):208-19. PubMed ID: 16331665
[TBL] [Abstract][Full Text] [Related]
9. Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR Stability.
Matsumoto H; Yamamoto Y; Shiota M; Kuruma H; Beraldi E; Matsuyama H; Zoubeidi A; Gleave M
Cancer Res; 2013 Aug; 73(16):5206-17. PubMed ID: 23786771
[TBL] [Abstract][Full Text] [Related]
10. Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability.
Lee KB; Jeon JH; Choi I; Kwon OY; Yu K; You KH
Biochem Biophys Res Commun; 2008 Feb; 366(4):905-9. PubMed ID: 18082619
[TBL] [Abstract][Full Text] [Related]
11. Promotion of cell proliferation by clusterin in the renal tissue repair phase after ischemia-reperfusion injury.
Nguan CY; Guan Q; Gleave ME; Du C
Am J Physiol Renal Physiol; 2014 Apr; 306(7):F724-33. PubMed ID: 24477687
[TBL] [Abstract][Full Text] [Related]
12. Clusterin in the eye: An old dog with new tricks at the ocular surface.
Fini ME; Bauskar A; Jeong S; Wilson MR
Exp Eye Res; 2016 Jun; 147():57-71. PubMed ID: 27131907
[TBL] [Abstract][Full Text] [Related]
13. Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma.
Wang C; Jin G; Jin H; Wang N; Luo Q; Zhang Y; Gao D; Jiang K; Gu D; Shen Q; Huo X; Hu F; Ge T; Zhao F; Chu W; Shu H; Yao M; Cong W; Qin W
Oncotarget; 2015 Feb; 6(5):2903-16. PubMed ID: 25609201
[TBL] [Abstract][Full Text] [Related]
14. The Down-Regulation of Clusterin Expression Enhances the αSynuclein Aggregation Process.
Lenzi C; Ramazzina I; Russo I; Filippini A; Bettuzzi S; Rizzi F
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003328
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells.
Sosa MS; Girotti MR; Salvatierra E; Prada F; de Olmo JA; Gallango SJ; Albar JP; Podhajcer OL; Llera AS
Proteomics; 2007 Nov; 7(22):4123-34. PubMed ID: 17994631
[TBL] [Abstract][Full Text] [Related]
16. The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.
Park S; Mathis KW; Lee IK
Rev Endocr Metab Disord; 2014 Mar; 15(1):45-53. PubMed ID: 24097125
[TBL] [Abstract][Full Text] [Related]
17. Clusterin as a therapeutic target.
Wilson MR; Zoubeidi A
Expert Opin Ther Targets; 2017 Feb; 21(2):201-213. PubMed ID: 27978767
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-Based Analysis of Molecular Pathways for Clusterin Functions in Kidney Cells.
Dairi G; Guan Q; Roshan-Moniri M; Collins CC; Ong CJ; Gleave ME; Nguan CY; Du C
J Cell Physiol; 2016 Dec; 231(12):2628-38. PubMed ID: 27155085
[TBL] [Abstract][Full Text] [Related]
19. Spatiotemporal expression patterns of clusterin in the mouse inner ear.
Lee S; Shin JO; Sagong B; Kim UK; Bok J
Cell Tissue Res; 2017 Oct; 370(1):89-97. PubMed ID: 28687930
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the expression of CLU isoforms in endometrial proliferative diseases.
Fuzio P; Valletti A; Napoli A; Napoli G; Cormio G; Selvaggi L; Liuni S; Pesole G; Maiorano E; Perlino E
Int J Oncol; 2013 Jun; 42(6):1929-44. PubMed ID: 23589125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
